|Articles|March 24, 2022
Kayentis Launches Platform for DCTs
Platform to alleviate logistical challenges with patients.
Advertisement
Kayentis announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and decentralized clinical trials (DCT).
This streamlined platform alleviates many logistical hurdles in bringing key elements of the clinical trial to patients’ homes, while vastly improving how patients and sites use DCT technologies.
Read more about Kayentis' new platform here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
